• Explore /
  • Poster
  • / Incidence of posttransplantation lymphoproliferative disorder (PTLD) following allogeneic blood or marrow transplantation (alloBMT) using post-transplantation cyclophosphamide (PT-Cy) for graft-versus-host disease (GVHD) prophylaxis.

Incidence of posttransplantation lymphoproliferative disorder (PTLD) following allogeneic blood or marrow transplantation (alloBMT) using post-transplantation cyclophosphamide (PT-Cy) for graft-versus-host disease (GVHD) prophylaxis.

Abstract Poster

Authors

Jennifer Kanakry

Jennifer Ann Kanakry

Johns Hopkins School of Medicine, Baltimore, MD

Jennifer Ann Kanakry , Yvette L. Kasamon , Lode J. Swinnen , Javier Bolanos-Meade , Douglas Gladstone , Heather J. Symons , Huzefa J. Mogri , Christopher George Kanakry , Christopher D Gocke , Leo Luznik , Ephraim Joseph Fuchs , Richard J. Jones , Richard F. Ambinder

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Leukemia, Myelodysplasia, and Transplantation

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Allogeneic Bone Marrow

Citation

J Clin Oncol 31, 2013 (suppl; abstr 7009)

DOI

10.1200/jco.2013.31.15_suppl.7009

Abstract #

7009

Poster Bd #

1

Abstract Disclosures

Similar Posters

First Author: Omar Albanyan

First Author: Marcus Messmer

First Author: Henry Jacob Conter

First Author: Sylvain Choquet